By Dr Briony Kate Larance

Books

Gibson AE; Larance BK; Roxburgh AD; Degenhardt LJ; Black E, 2007, The extent of diversion of fentanyl for non-medical puposes in Australia: What do we know?, National Drug & Alcohol Research Centre, Randwick, NSW

Book Chapters

Farrell M; Larance B; Breen C, 2020, 'Opioids', in Geddes JR; Andreasen NC; Goodwin GM (ed.), New Oxford Textbook of Psychiatry, Oxford University Press, pp. 507 - 518, http://dx.doi.org/10.1093/med/9780198713005.003.0051

Journal articles

Beck AK; Larance B; Manning V; Deane FP; Baker AL; Hides L; Shakeshaft A; Argent A; Kelly PJ, 2025, 'Exploring the potential of Self-Management and Recovery Training (SMART Recovery) mutual-help groups for supporting people who use methamphetamine: A qualitative study examining participant experience of initiation and engagement', Journal of Substance Use and Addiction Treatment, 169, http://dx.doi.org/10.1016/j.josat.2024.209570

Campbell G; Larance B, 2024, 'Commentary on Yang et al.: The need for a renewed focus on identifying and responding to chronic pain among people with substance use disorders', Addiction, 119, pp. 1902 - 1903, http://dx.doi.org/10.1111/add.16654

Wells M; Kelly PJ; Mullaney L; Lee ML; Stirling R; Etter S; Larance B, 2024, 'Predictors of alcohol and other drug treatment completion among young people accessing residential and community-based treatment: A retrospective analysis of routinely collected service data', Addiction, 119, pp. 1813 - 1825, http://dx.doi.org/10.1111/add.16602

Wells M; Kelly PJ; Robson D; Haynes C; Hatton E; Larance B, 2024, 'Systematic review of treatment completion rates and correlates among young people accessing alcohol and other drug treatment', Drug and Alcohol Dependence, 262, http://dx.doi.org/10.1016/j.drugalcdep.2024.111376

Haynes CJ; Beck AK; Wells M; Hatton EL; Kelly PJ; Tan WJ; Larance B, 2024, 'Women and opioid use disorder treatment: A scoping review of experiences, use of patient-reported experience measures, and integration of person-centred care principles', International Journal of Drug Policy, 130, http://dx.doi.org/10.1016/j.drugpo.2024.104520

Rushton CM; Kelly PJ; Thomas T; Beck AK; Townsend C; Baker AL; Manning V; Argent A; Deane FP; Hides L; Hitsman B; Velleman R; Velleman G; Larance B, 2024, 'SMART Family and Friends: Feasibility and outcomes of a video-conference delivered intervention for families impacted by another's methamphetamine use', Journal of Substance Use and Addiction Treatment, 161, http://dx.doi.org/10.1016/j.josat.2024.209355

Farrell M; Shahbazi J; Chambers M; Byrne M; Gholami J; Zahra E; Grebely J; Lintzeris N; Larance B; Ali R; Nielsen S; Dunlop A; Dore GJ; McDonough M; Montebello M; Weiss R; Rodgers C; Cook J; Degenhardt L, 2024, '96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104390

Tran AD; Grebely J; Chambers M; Degenhardt L; Farrell M; Bajis S; Larance B, 2024, 'Health utility among people who regularly use opioids in Australia', Drug and Alcohol Review, 43, pp. 997 - 1012, http://dx.doi.org/10.1111/dar.13823

Campbell G; Settumba S; Hopkins R; Nielsen S; Larance B; Bruno R; Cohen M; Degenhardt L; Shanahan M, 2024, 'A discrete choice experiment: Understanding patient preferences for managing chronic non-cancer pain', European Journal of Pain, http://dx.doi.org/10.1002/ejp.4760

Larance B; Ingram I; Haynes C; Buckfield L; Goh CWM; Kelly PJ, 2024, 'New South Wales alcohol and other drug service providers' perceptions of the relative importance of client variables for determining treatment need', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13952

van de Ven K; Deane FP; Kelly PJ; Larance B; Beck AK, 2024, 'Online SMART Recovery mutual-help groups: a comparison of the characteristics and experiences of men living in rural and urban regions of Australia', Rural and Remote Health, 24, http://dx.doi.org/10.22605/RRH8861

Settumba S; Shahbazi J; Byrne M; Degenhardt L; Grebely J; Larance B; Nielsen S; Lintzeris N; Ali R; Rodgers C; Blazey A; Weiss R; Dunlop A; McDonough M; Cook J; Farrell M, 2024, 'Provider costs of treating opioid dependence with extended-release buprenorphine in Australia', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13956

Pocuca N; Tisdale C; Campbell G; Beck AK; Ellem R; Quinn CA; Kelly PJ; Larance B; Baker AL; Connor JP; Marsden J; Chan GCK; Connelly L; Lenzen S; Farrell M; Hides L, 2024, 'Routine outcome monitoring and feedback in alcohol and other drug treatment: A qualitative study of client perspectives on implementation', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13962

Degenhardt L; Clark B; Macpherson G; Leppan O; Nielsen S; Zahra E; Larance B; Kimber J; Martino-Burke D; Hickman M; Farrell M, 2024, 'Buprenorphine Versus Methadone for the Treatment of Opioid Dependence: A Systematic Review and Meta-Analysis of Randomised and Observational Studies', Drug and Alcohol Dependence, 260, pp. 110531 - 110531, http://dx.doi.org/10.1016/j.drugalcdep.2023.110531

Beck AK; Waks S; Argent A; Deane FP; Larance B; Manning V; Baker AL; Hides L; Kelly PJ, 2023, 'The benefits and challenges of virtual SMART recovery mutual-help groups: Participant and facilitator perspectives', International Journal of Drug Policy, 120, http://dx.doi.org/10.1016/j.drugpo.2023.104174

Degenhardt L; Clark B; Macpherson G; Leppan O; Nielsen S; Zahra E; Larance B; Kimber J; Martino-Burke D; Hickman M; Farrell M, 2023, 'Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies', The Lancet Psychiatry, 10, pp. 386 - 402, http://dx.doi.org/10.1016/S2215-0366(23)00095-0

Rushton C; Kelly PJ; Raftery D; Beck A; Larance B, 2023, 'The effectiveness of psychosocial interventions for family members impacted by another's substance use: A systematic review and meta-analysis', Drug and Alcohol Review, 42, pp. 960 - 977, http://dx.doi.org/10.1111/dar.13607

Beck AK; Larance B; Baker AL; Deane FP; Manning V; Hides L; Kelly PJ, 2023, 'Supporting people affected by problematic alcohol, substance use and other behaviours under pandemic conditions: A pragmatic evaluation of how SMART recovery Australia responded to COVID-19', Addictive Behaviors, 139, http://dx.doi.org/10.1016/j.addbeh.2022.107577

Robinson LD; Walter EE; Deane FP; Larance BK, 2023, 'Comorbid eating disorders among women receiving treatment for substance use disorders: a systematic review and meta-analysis', Addiction Research and Theory, 31, pp. 114 - 126, http://dx.doi.org/10.1080/16066359.2022.2127692

Beck AK; Larance B; Manning V; Hides L; Baker AL; Deane FP; Shakeshaft A; Raftery D; Kelly PJ, 2023, 'Online SMART Recovery mutual support groups: Characteristics and experience of adults seeking treatment for methamphetamine compared to those seeking treatment for other addictive behaviours', Drug and Alcohol Review, 42, pp. 20 - 26, http://dx.doi.org/10.1111/dar.13544

Nielsen S; Tse WC; Larance B, 2022, 'Opioid agonist treatment for people who are dependent on pharmaceutical opioids', Cochrane Database of Systematic Reviews, 2022, http://dx.doi.org/10.1002/14651858.CD011117.pub3

Osborne B; Larance B; Ivers R; Deane FP; Robinson LD; Kelly PJ, 2022, 'Systematic review of guidelines for managing physical health during treatment for substance use disorders: Implications for the alcohol and other drug workforce', Drug and Alcohol Review, 41, pp. 1367 - 1390, http://dx.doi.org/10.1111/dar.13504

Robinson LD; Kelly PJ; Larance BK; Griffiths S; Deane FP, 2022, 'Eating Disorder Behaviours and Substance Use in Women Attending Treatment for Substance Use Disorders: a Latent Class Analysis', International Journal of Mental Health and Addiction, 20, pp. 2006 - 2023, http://dx.doi.org/10.1007/s11469-021-00497-z

Hopkins RE; Campbell G; Degenhardt L; Lintzeris N; Larance B; Nielsen S; Gisev N, 2022, 'Self-reported challenges obtaining ongoing prescription opioids among Australians with chronic non-cancer pain', International Journal of Drug Policy, 105, http://dx.doi.org/10.1016/j.drugpo.2022.103708

Zahra E; Chen R; Nielsen S; Tran AD; Santo T; Degenhardt L; Farrell M; Byrne J; Ali R; Larance B, 2022, 'Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross-sectional survey of Australian treatment clients', Drug and Alcohol Review, 41, pp. 841 - 850, http://dx.doi.org/10.1111/dar.13437

Farrell M; Shahbazi J; Byrne M; Grebely J; Lintzeris N; Chambers M; Larance B; Ali R; Nielsen S; Dunlop A; Dore GJ; McDonough M; Montebello M; Nicholas T; Weiss R; Rodgers C; Cook J; Degenhardt L, 2022, 'Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence', International Journal of Drug Policy, 100, http://dx.doi.org/10.1016/j.drugpo.2021.103492

Tran AD; Chen R; Nielsen S; Zahra E; Degenhardt L; Santo T; Farrell M; Larance B, 2022, 'Economic analysis of out-of-pocket costs among people in opioid agonist treatment: A cross-sectional survey in three Australian jurisdictions', International Journal of Drug Policy, 99, http://dx.doi.org/10.1016/j.drugpo.2021.103472

Kelly PJ; Hatton EL; Hinsley K; Davis E; Larance B, 2021, 'Preliminary psychometric evaluation of the patient reported experience measure for addiction treatment (PREMAT)', Addictive Behaviors, 123, http://dx.doi.org/10.1016/j.addbeh.2021.107048

Kelly PJ; McCreanor K; Beck AK; Ingram I; O'Brien D; King A; McGlaughlin R; Argent A; Ruth M; Hansen BS; Andersen D; Manning V; Shakeshaft A; Hides L; Larance B, 2021, 'SMART Recovery International and COVID-19: Expanding the reach of mutual support through online groups', Journal of Substance Abuse Treatment, 131, http://dx.doi.org/10.1016/j.jsat.2021.108568

Kelly PJ; Beck AK; Deane FP; Larance B; Baker AL; Hides L; Manning V; Shakeshaft A; Neale J; Kelly JF; Oldmeadow C; Searles A; Palazzi K; Lawson K; Treloar C; Gray RM; Argent A; McGlaughlin R, 2021, 'Feasibility of a mobile health app for routine outcome monitoring and feedback in SMART recovery mutual support groups: Stage 1 mixed methods pilot study', Journal of Medical Internet Research, 23, http://dx.doi.org/10.2196/25217

Nielsen S; Gisev N; Leung J; Clare P; Bruno R; Lintzeris N; Larance B; Blyth F; Hall W; Cohen M; Degenhardt L; Farrell M; Campbell G, 2021, 'Clinical correlates and outcomes associated with pregabalin use among people prescribed opioids for chronic non-cancer pain: A five-year prospective cohort study', British Journal of Clinical Pharmacology, 87, pp. 3092 - 3104, http://dx.doi.org/10.1111/bcp.14715

Beck AK; Larance B; Deane FP; Baker AL; Manning V; Hides L; Shakeshaft A; Argent A; Kelly PJ, 2021, 'The use of Australian SMART Recovery groups by people who use methamphetamine: Analysis of routinely-collected nationwide data', Drug and Alcohol Dependence, 225, http://dx.doi.org/10.1016/j.drugalcdep.2021.108814

Nielsen S; Sanfilippo P; Belackova V; Day C; Silins E; Lintzeris N; Bruno R; Grebely J; Lancaster K; Ali R; Bell J; Dietze P; Degenhardt L; Farrell M; Larance B, 2021, 'Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian cities', Addiction, 116, pp. 1482 - 1494, http://dx.doi.org/10.1111/add.15297

Osborne B; Kelly PJ; Robinson LD; Ivers R; Deane FP; Larance B, 2021, 'Facilitators and barriers to integrating physical health care during treatment for substance use: A socio-ecological analysis', Drug and Alcohol Review, 40, pp. 607 - 616, http://dx.doi.org/10.1111/dar.13197

Kelly PJ; Deane FP; Davis EL; Hudson S; Robinson LD; Keane CA; Hatton EL; Larance B, 2021, 'Routine outcome measurement in specialist non-government alcohol and other drug treatment services: Establishing effectiveness indicators for the NADAbase', Drug and Alcohol Review, 40, pp. 540 - 552, http://dx.doi.org/10.1111/dar.13191

Degenhardt L; Hungerford P; Nielsen S; Bruno R; Larance B; Clare PJ; Dobbins T; Hall W; Cohen M; Blyth F; Lintzeris N; Farrell M; Campbell G, 2021, 'Pharmaceutical Opioid Use Patterns and Indicators of Extramedical Use and Harm in Adults with Chronic Noncancer Pain, 2012-2018', JAMA Network Open, 4, http://dx.doi.org/10.1001/jamanetworkopen.2021.3059

Darke S; Duflou J; Larance B; Farrell M; Lappin J, 2021, 'Characteristics and circumstances of death related to buprenorphine toxicity in Australia', Drug and Alcohol Dependence, 218, http://dx.doi.org/10.1016/j.drugalcdep.2020.108360

Campbell G; Noghrehchi F; Nielsen S; Clare P; Bruno R; Lintzeris N; Cohen M; Blyth F; Hall W; Larance B; Hungerford P; Dobbins T; Farrell M; Degenhardt L, 2020, 'Risk factors for indicators of opioid-related harms amongst people living with chronic non-cancer pain: Findings from a 5-year prospective cohort study', EClinicalMedicine, 28, http://dx.doi.org/10.1016/j.eclinm.2020.100592

Larance B; Byrne M; Lintzeris N; Nielsen S; Grebely J; Degenhardt L; Shahbazi J; Shanahan M; Lancaster K; Dore G; Ali R; Farrell M; Treloar C, 2020, 'Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: Protocol for the CoLAB study', BMJ Open, 10, pp. e034389, http://dx.doi.org/10.1136/bmjopen-2019-034389

Kelly PJ; Beck AK; Baker AL; Deane FP; Hides L; Manning V; Shakeshaft A; Larance B; Neale J; Kelly J; Oldmeadow C; Searles A; Treloar C; Gray RM; Argent A; McGlaughlin R, 2020, 'Feasibility of a mobile health app for routine outcome monitoring and feedback in mutual support groups coordinated by SMART recovery Australia: Protocol for a pilot study', JMIR Research Protocols, 9, http://dx.doi.org/10.2196/15113

Larance B; Degenhardt L; Grebely J; Nielsen S; Bruno R; Dietze P; Lancaster K; Larney S; Santo T; Shanahan M; Memedovic S; Ali R; Farrell M, 2020, 'Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia', Addiction, 115, pp. 1295 - 1305, http://dx.doi.org/10.1111/add.14941

Osborne B; Kelly PJ; Larance B; Robinson LD; Ivers R; Deane FP; Webber A; Kelly D, 2020, 'Substance Use and Co-occurring Physical Health Problems: File Review of a Residential Drug and Alcohol Treatment Service', Journal of Dual Diagnosis, 16, pp. 250 - 259, http://dx.doi.org/10.1080/15504263.2019.1704960

Santo T; Larance B; Bruno R; Gisev N; Nielsen S; Degenhardt L; Campbell G, 2020, 'Correlates of indicators of potential extra-medical opioid use in people prescribed opioids for chronic non-cancer pain', Drug and Alcohol Review, 39, pp. 128 - 134, http://dx.doi.org/10.1111/dar.13021

Jacka B; Larance B; Copeland J; Burns L; Farrell M; Jackson E; Degenhardt L, 2020, 'Health care engagement behaviors of men who use performance- and image-enhancing drugs in Australia', Substance Abuse, 41, pp. 139 - 145, http://dx.doi.org/10.1080/08897077.2019.1635954

Nielsen S; Picco L; Campbell G; Lintzeris N; Larance B; Farrell M; Degenhardt L; Bruno R, 2020, 'Development of a brief patient-administered screening tool for prescription opioid dependence for primary care settings', Pain Medicine (United States), 21, pp. E79 - E88, http://dx.doi.org/10.1093/pm/pnz213

Peacock A; Gisev N; Memedovic S; Larance B; Brown J; Cairns R; Buckley N; Farrell M; Degenhardt L, 2020, 'Opioid use and harms associated with a sustained-release tapentadol formulation: A post-marketing surveillance study.', Drug Alcohol Depend, 206, pp. 107697, http://dx.doi.org/10.1016/j.drugalcdep.2019.107697

Gisev N; Nielsen S; Campbell G; Santo T; Mant A; Bruno R; Cohen M; Hall WD; Larance B; Lintzeris N; Farrell M; Degenhardt L, 2019, 'Antidepressant Use among People Prescribed Opioids for Chronic Noncancer Pain', Pain Medicine (United States), 20, pp. 2450 - 2458, http://dx.doi.org/10.1093/pm/pnz009

Darke S; Farrell M; Duflou J; Larance B; Lappin J, 2019, 'Circumstances of death of opioid users being treated with naltrexone', Addiction, 114, pp. 2000 - 2007, http://dx.doi.org/10.1111/add.14729

Back to profile page